SI-Bone Inc (NASDAQ:SIBN) insider Scott A. Yerby sold 10,133 shares of the company’s stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $16.05, for a total value of $162,634.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of SIBN stock traded down $0.01 on Friday, hitting $15.93. The company had a trading volume of 74,058 shares, compared to its average volume of 85,635. The stock has a market cap of $394.98 million and a price-to-earnings ratio of -22.15. The company has a current ratio of 13.06, a quick ratio of 14.73 and a debt-to-equity ratio of 0.47. SI-Bone Inc has a twelve month low of $14.08 and a twelve month high of $23.03.
SI-Bone (NASDAQ:SIBN) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.13). The firm had revenue of $14.99 million during the quarter. Sell-side analysts forecast that SI-Bone Inc will post -1.45 earnings per share for the current year.
SIBN has been the subject of several recent research reports. Zacks Investment Research raised SI-Bone from a “sell” rating to a “hold” rating in a research note on Saturday, January 26th. ValuEngine cut SI-Bone from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $24.75.
SI-Bone Company Profile
SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.
Featured Article: Net Margin
Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with MarketBeat.com's FREE daily email newsletter.